Calliditas Therapeutics AB
STO:CALTX

Watchlist Manager
Calliditas Therapeutics AB Logo
Calliditas Therapeutics AB
STO:CALTX
Watchlist
Price: 208 SEK 0.87% Market Closed
Market Cap: 11.2B SEK
Have any thoughts about
Calliditas Therapeutics AB?
Write Note

Calliditas Therapeutics AB
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Calliditas Therapeutics AB
Other Operating Expenses Peer Comparison

Comparables:
CAMX
S
SECARE
IRLAB A
MOB
I
FLERIE

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Calliditas Therapeutics AB
STO:CALTX
Other Operating Expenses
kr22.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Other Operating Expenses
-kr813k
CAGR 3-Years
83%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Other Operating Expenses
-kr245m
CAGR 3-Years
-43%
CAGR 5-Years
-62%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Other Operating Expenses
-kr633k
CAGR 3-Years
N/A
CAGR 5-Years
59%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Other Operating Expenses
kr1.1m
CAGR 3-Years
-43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Other Operating Expenses
-kr87.9m
CAGR 3-Years
-16%
CAGR 5-Years
-7%
CAGR 10-Years
N/A

See Also

What is Calliditas Therapeutics AB's Other Operating Expenses?
Other Operating Expenses
22.4m SEK

Based on the financial report for Jun 30, 2024, Calliditas Therapeutics AB's Other Operating Expenses amounts to 22.4m SEK.

What is Calliditas Therapeutics AB's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 1Y
41%

Over the last year, the Other Operating Expenses growth was 41%.

Back to Top